<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Merz KE</submitter><funding>NIDDK NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Cancer Institute</funding><funding>Larry L. Hillblom Foundation</funding><funding>NCI NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases</funding><pagination>424</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8776765</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(1)</volume><pubmed_abstract>Mitochondrial dysfunction is implicated in skeletal muscle insulin resistance. Syntaxin 4 (STX4) levels are reduced in human diabetic skeletal muscle, and global transgenic enrichment of STX4 expression improves insulin sensitivity in mice. Here, we show that transgenic skeletal muscle-specific STX4 enrichment (skmSTX4tg) in mice reverses established insulin resistance and improves mitochondrial function in the context of diabetogenic stress. Specifically, skmSTX4tg reversed insulin resistance caused by high-fat diet (HFD) without altering body weight or food consumption. Electron microscopy of wild-type mouse muscle revealed STX4 localisation at or proximal to the mitochondrial membrane. STX4 enrichment prevented HFD-induced mitochondrial fragmentation and dysfunction through a mechanism </pubmed_abstract><journal>Nature communications</journal><pubmed_title>Enrichment of the exocytosis protein STX4 in skeletal muscle remediates peripheral insulin resistance and alters mitochondrial dynamics via Drp1.</pubmed_title><pmcid>PMC8776765</pmcid><funding_grant_id>R01 DK102233</funding_grant_id><funding_grant_id>#2020-D-018-FEL</funding_grant_id><funding_grant_id>P30CA33572</funding_grant_id><funding_grant_id>DK1129712</funding_grant_id><funding_grant_id>P30 CA033572</funding_grant_id><funding_grant_id>DK102233</funding_grant_id><funding_grant_id>R01 DK067912</funding_grant_id><funding_grant_id>DK067912</funding_grant_id><pubmed_authors>Veluthakal R</pubmed_authors><pubmed_authors>Jiang L</pubmed_authors><pubmed_authors>Zhou C</pubmed_authors><pubmed_authors>Huss JM</pubmed_authors><pubmed_authors>Dai W</pubmed_authors><pubmed_authors>McCown EM</pubmed_authors><pubmed_authors>Hamilton A</pubmed_authors><pubmed_authors>Oh E</pubmed_authors><pubmed_authors>Thurmond DC</pubmed_authors><pubmed_authors>Merz KE</pubmed_authors><pubmed_authors>Fueger PT</pubmed_authors><pubmed_authors>Hwang J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Enrichment of the exocytosis protein STX4 in skeletal muscle remediates peripheral insulin resistance and alters mitochondrial dynamics via Drp1.</name><description>Mitochondrial dysfunction is implicated in skeletal muscle insulin resistance. Syntaxin 4 (STX4) levels are reduced in human diabetic skeletal muscle, and global transgenic enrichment of STX4 expression improves insulin sensitivity in mice. Here, we show that transgenic skeletal muscle-specific STX4 enrichment (skmSTX4tg) in mice reverses established insulin resistance and improves mitochondrial function in the context of diabetogenic stress. Specifically, skmSTX4tg reversed insulin resistance caused by high-fat diet (HFD) without altering body weight or food consumption. Electron microscopy of wild-type mouse muscle revealed STX4 localisation at or proximal to the mitochondrial membrane. STX4 enrichment prevented HFD-induced mitochondrial fragmentation and dysfunction through a mechanism </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2025-05-29T21:30:16.51Z</modification><creation>2025-05-29T21:30:16.51Z</creation></dates><accession>S-EPMC8776765</accession><cross_references><pubmed>35058456</pubmed><doi>10.1038/s41467-022-28061-w</doi></cross_references></HashMap>